Investors & Media

Jenene Thomas
Vice President, Investor Relations and Business Administration

Press Releases

8-Feb-2012	UNIGENE ANNOUNCES KEY APPOINTMENTS AS BIOTECHNOLOGIES STRATEGIC BUSINESS UNIT CONTINUES TO GROW IN 2012
7-Feb-2012	Unigene to Present at the 14th Annual BIO CEO & Investor Conference on
1-Feb-2012	UNIGENE RECEIVES 2012 DRUG DELIVERY PARTNERSHIPS INDUSTRY ACHIEVEMENT AWARD
12-Jan-2012	Unigene Laboratories Granted US Patent for Peptide-Based Technology for Treatment of Obesity
9-Jan-2012	UNIGENE PROVIDES 2012 BUSINESS OUTLOOK
4-Jan-2012	Unigene to Present at Biotech Showcase™ 2012 in San Francisco on January 9
19-Dec-2011	UNIGENE’S 2011 YEAR IN REVIEW – KEY ELEMENTS IN PLACE TO ADDRESS DEBT IN 2012
7-Dec-2011	Unigene to Present at the Oppenheimer 22nd Annual Healthcare Conference on December 13, 2011
5-Dec-2011	Unigene Regains Exclusive Worldwide Rights of Oral PTH from GSK
30-Nov-2011	Unigene’s Proprietary Peptelligence™ Platform used to Commence Cara Therapeutics Phase 1 Clinical Trial of Oral Novel Peripherally-Acting Kappa Opioid Agonist